Effect of anti-IgE therapy in patients with peanut allergy

New England Journal of Medicine

Volumn 348, Issue 11, 2003, Pages 986-993

  Leung, Donald Y M ^a   Sampson, Hugh A ^b   Yunginger, John W ^c   Burks Jr , A Wesley ^d   Schneider, Lynda C ^e   Wortel, Cornelis H ^f   Davis, Frances M ^g   Hyun, John D ^g   Shanahan Jr , William R ^g  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

^d ARKANSAS CHILDREN S HOSPITAL   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f Clin Quest   (United States)

^g Tanox   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FC RECEPTOR; IMMUNOGLOBULIN E; OMALIZUMAB; PLACEBO;

ADOLESCENT; ADULT; ANAPHYLAXIS; ARTICLE; BINDING AFFINITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; EDEMA; ERYTHEMA; FEMALE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PEANUT ALLERGY; PRIORITY JOURNAL; PROTEIN BINDING; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TREATMENT OUTCOME; TREATMENT PLANNING;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PEANUT HYPERSENSITIVITY;

EID: 0037434895     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa022613     Document Type: Article

References (31)

1. Sicherer SH, Burks AW, Sampson HA. Clinical features of acute allergic reactions to peanut and tree nuts in children. Pediatrics 1998;102:131-2.
2. Atkins FM, Steinberg SS, Metcalfe DD. Evaluation of immediate adverse reactions to foods in adult patients. I. Correlation of demographic, laboratory, and prick skin test data with response to controlled oral food challenge. J Allergy Clin Immunol 1985;75:348-55.
3. Kinet JP. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol 1999;17:931-72.
4. Long A. The nuts and bolts of peanut allergy. N Engl J Med 2002;346:1320-2.
5. Miyajima I, Dombrowicz D, Martin TR, Ravetch JV, Kinet J-P, Galli SJ. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gamma RIII; assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J Clin Invest 1997;99:901-14.
6. Oettgen HC, Martin TR, Wynshaw-Boris A, Deng C, Drazen JM, Leder P. Active anaphylaxis in IgE-deficient mice. Nature 1994;370:367-70.
7. Tariq SM, Stevens M, Matthews S, Ridout S, Twiselton R, Hide DW. Cohort study of peanut and tree nut sensitisation by age of 4 years. BMJ 1996;313:514-7.
8. Sicherer SH, Munoz-Furlong A, Burks AW, Sampson HA. Prevalence of peanut and tree nut allergy in the US determined by a random digit dial telephone survey. J Allergy Clin Immunol 1999;103:559-62.
9. Yocum MW, Butterfield JH, Klein JS, Volcheck GW, Schroeder DR, Silverstein MD. Epidemiology of anaphylaxis in Olmsted County: a population-based study. J Allergy Clin Immunol 1999;104:452-6.
10. Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001;107:191-3.
11. Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992;327:380-4.
12. Hourihane JO. Peanut allergy - current status and future challenges. Clin Exp Allergy 1997;27:1240-6.
13. Vander Leek TK, Liu AH, Stefanski K, Blacker B, Bock SA. The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Pediatr 2000;137:749-55.
14. The use of epinephrine in the treatment of anaphylaxis. J Allergy Clin Immunol 1994;94:666-8.
15. Sampson HA. Peanut allergy. N Engl J Med 2002;346:1294-9.
16. Idem. Food allergy. 2. Diagnosis and management. J Allergy Clin Immunol 1999;103: 981-9.
17. Hallett R, Haapanen LAD, Teuber SS. Food allergies and kissing. N Engl J Med 2002;346:1833-4.
18. Nelson HS, Lahr J, Rule R, Bock SA, Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997;99:744-51.
19. Chang TW. Pharmacological basis of anti-IgE therapy. Nat Biotechnol 2000;18:157-62.
20. Davis FM, Gossett LA, Pinkston KL, et al. Can anti-IgE be used to treat allergy? Springer Semin Immunopathol 1993;15:51-73.
21. Kolbinger F, Saldanha J, Hardman N, Bendig MM. Humanization of a mouse antihuman IgE antibody: a potential therapeutic for IgE-mediated allergies. Protein Eng 1993;6:971-80.
22. MacGlashan DW Jr, Bochner BS, Adelman DC, et al. Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997;158:1438-45.
23. MacGlashan D Jr, McKenzie-White J, Chichester K, et al. In vitro regulation of FcepsilonRIalpha expression on human basophils by IgE antibody. Blood 1998;91:1633-43.
24. van Neerven RJJ, van Roomen CPAA, Thomas WR, de Boer M, Knol EF, Davis FM. Humanized anti-IgE mAb Hu-901 prevents the activation of allergen-specific T-cells. Int Arch Allergy Immunol 2001;124:400-2.
25. Come J, Djukanovic R, Thomas L, et al. Effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics. J Clin Invest 1997;99:879-87.
26. Sampson HA, Ho DG. Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol 1997;100:444-51.
27. Burks AW, Sampson HA. Double-blind, placebo-controlled trial of oral cromolyn in children with atopic dermatitis and documented food hypersensitivity. J Allergy Clin Immunol 1988;81:417-23.
28. Halken S, Host A, Hansen LG, Osterballe O. Safety of a new, ultrafiltrated whey hydrolysate formula in children with cow milk allergy: a clinical investigation. Pediatr Allergy Immunol 1993;4:53-9.
29. Sampson HA, Bernhisel-Broadbent J, Yang E, Scanlon SM. Safety of casein hydrolysate formula in children with cow milk allergy. J Pediatr 1991;118:520-5.
30. Sampson HA, James JM, Bernhisel-Broadbent J. Safety of an amino acid-derived infant formula in children allergic to cow milk. Pediatrics 1992;90:463-5.
31. Sampson HA, Jolie PL. Increased plasma histamine concentrations after food challenges in children with atopic dermatitis. N Engl J Med 1984;311:372-6.